Psychiatric Times World CME Conference

CBD and THC? What's the difference and why does it matter?

One researcher shares his evidence for the usage of psilocybin in psychiatry.

Opioid use disorder—how can we battle the epidemic of overdoses?

What are the long term psychiatric and neuropsychiatric complications of COVID-19?

Treating women of reproductive age who have depression can be difficult. Here’s an overview on the subject from the 2022 Annual Psychiatric Times™ World CME Conference.

The resistance against "magic mushrooms"—is it justified?

Medication, counseling, and support—just as important in substance use disorder treatment as any other brain disease.

Can we inherit our parents’ trauma? Research points to yes.

What is a mood disorder and what are the early warning signs? What treatments are available?

Here's how to listen to patients and offer selective reflections.

What are the latest treatments in difficult to treat depression?

The endocrine system is an important puzzle piece when addressing psychiatric disorders.

How do you screen for childhood trauma? One doctor at the 2022 Annual Psychiatric Times™ World CME Conference in San Diego, one doctor shared his most helpful tips.

Despite mixed data, there are some psychopharmacological options for treating PTSD.

What are some of the most exciting emerging and established methods?

What are the key differences?

Here's why more research is important to help us better understand the effects of cannabis on our patients.

How can we, as clinicians, understand how trauma has affected our patients and respond in the most effective way?

Is it prolonged grief or MDD? Expert shares insights at premiere annual meeting.

The president of the San Diego Psychiatric Society gives us a glimpse into the city for the upcoming 2022 Annual Psychiatric Times World CME Conference.

What are their clinical differences?

Which treatment approaches are the state-of-the-art for helping this patient population?

How do you choose medications based on the biologic abnormalities that are known to occur in bipolar illness?

These 3 essential steps best support patients with borderline personality disorder, according to Carl Fleisher, MD.

Cultural differences between patients and physician are hard to avoid. How can you best work with diverse patients?

Transgender youth are at increased risk for a number of psychiatric morbidities. Gender identity conversion therapy can make them worse.

Sheldon Preskorn, MD, shares insights into drug mechanisms and delivery to better help patients with major depressive disorder.

Phase 3 results on MDMA-assisted therapy look promising for the treatment of PTSD. What other disorders can psychedelics help treat?

Sidney Zisook, MD, shares insights into defining depression diagnosis.